Teladoc Health, Inc. (TDOC) News
Follow Teladoc Health, Inc. (TDOC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 38 public stories across 11 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Teladoc Shares Jump 24.2% After Third-Quarter Results
Teladoc shares rose 24.2% in morning trading after the company reported third-quarter results that exceeded its adjusted EBITDA guidance and put revenue near the upper end of its forecast.
EARNINGS | Oct 29, 2026, 03:18 PM UTC
M
Teladoc Health Reports Q3 Revenue of $605.1M, Loss Narrows
Third-quarter revenue fell 3.4% year over year to $605.1 million. Net loss narrowed to $26.93 million from $49.51 million, while diluted loss per share was $0.15 versus $0.28 a year earlier; Integrated Care growth was of
EQUITY | Oct 29, 2026, 02:41 PM UTC
M
Teladoc shares rise 27.7% to a three-month high after Q3 revenue beat
Teladoc shares were last up 27.7% after the company reported a third-quarter revenue beat.
EQUITY | Oct 29, 2026, 01:41 PM UTC
M
Teladoc Health shares gain 7.5% premarket after Q3 revenue beat
EQUITY | Oct 29, 2026, 08:14 AM UTC
M
Teladoc Health Reports Q3 2026 Revenue of $605.1 Million
Third-quarter revenue exceeded the FactSet consensus estimate of $588.1 million but declined 3.4% year over year. Teladoc guided to fourth-quarter 2026 revenue of $569.0 million to $615.0 million.
EQUITY | Oct 28, 2026, 09:33 PM UTC
M
Teladoc Health Shares Surge as Third-Quarter Revenue Tops Forecasts
Teladoc Health reported third-quarter revenue above forecasts, and its shares surged.
EARNINGS | Oct 28, 2026, 09:14 PM UTC
M
Teladoc Health reports Q3 net income
EARNINGS | Oct 28, 2026, 08:39 PM UTC
M
Teladoc Health Q3 Adjusted EBITDA Beats Consensus
Teladoc Health’s Q3 revenue fell 3% year over year.
EARNINGS | Oct 28, 2026, 08:31 PM UTC
M
Teladoc Health sets 2026 adjusted EBITDA outlook at $277M-$303M
EARNINGS | Oct 28, 2026, 08:23 PM UTC
M
Teladoc forecasts 2026 net loss per share of $0.95-$0.75
EARNINGS | Oct 28, 2026, 08:23 PM UTC
M
Teladoc Health cuts Q3 2026 net loss by 46%
EQUITY | Oct 28, 2026, 08:15 PM UTC
M
Teladoc Health Sees Fourth-Quarter Revenue of $569M-$615M
EARNINGS | Oct 28, 2026, 08:06 PM UTC
L
Teladoc Health sees a fourth-quarter per-share loss
EARNINGS | Oct 28, 2026, 08:06 PM UTC
M
Teladoc Health Sees FY Revenue of $2.4B-$2.44B
EARNINGS | Oct 28, 2026, 08:06 PM UTC
M
Teladoc Sees a Full-Year Loss per Share
Teladoc Health sees a full-year loss per share.
EQUITY | Oct 28, 2026, 08:06 PM UTC
M
Teladoc Health reports third-quarter loss per share
EQUITY | Oct 28, 2026, 08:06 PM UTC
M
Teladoc Health Reports Third-Quarter Revenue of $605.1 Million
EQUITY | Oct 28, 2026, 08:06 PM UTC
M
Teladoc Health to Announce Third-Quarter 2026 Financial Results
EQUITY | Oct 14, 2026, 08:05 PM UTC
L
Teladoc Health Chief Legal Officer Adam C. Vandervoort to Resign; Jonathan Dorfman Named Successor
Teladoc Health announced that Chief Legal Officer and Secretary Adam C. Vandervoort will resign effective November 1, 2026, and Senior Vice President Jonathan Dorfman will succeed him as Chief Legal Officer and Secretary
REGULATION | Sep 25, 2026, 12:33 PM UTC
L
Teladoc Health, Inc. (TDOC) Names New Chief Legal Officer
Adam Vandervoort will resign as Chief Legal Officer effective Nov. 1, 2026; Jonathan Dorfman will become CLO and Secretary on Nov. 2, 2026.Material DetailsContext by AI AnalystThis is a mid-cycle governance update with p
NEWS | Sep 25, 2026, 12:32 PM UTC
L
Teladoc Health Announces Chief Legal Officer Transition
Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026Jonathan DorfmanNEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. NYSE:TDOC, the global leader in virtual car
NEWS | Sep 25, 2026, 12:32 PM UTC
L
Teladoc Health issues NYSE Rule 303A.08 inducement awards
Teladoc Health announced it issued inducement awards to a new employee, effective September 1, 2026, for the commencement of Michael Grasher as Chief Financial Officer.
EQUITY | Sep 03, 2026, 08:37 PM UTC
L
Teladoc Health announces employee inducement awards under NYSE Rule 303A.08
Teladoc Health announced employee inducement awards under NYSE Rule 303A.08.
EQUITY | Sep 03, 2026, 08:35 PM UTC
L
Teladoc Health hires Michael Grasher as Chief Financial Officer
Teladoc Health has hired Michael Grasher as its Chief Financial Officer.
EQUITY | Aug 31, 2026, 08:44 PM UTC
L
TDOC - Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
TDOC - Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
EQUITY | Aug 17, 2026, 06:43 AM UTC
L
Teladoc Health Appoints Mark Anquillare to Board
Teladoc adds financial executive to board
EQUITY | Aug 03, 2026, 08:30 PM UTC
L
TDOC cuts annual revenue forecast
TDOC cuts annual revenue forecast
EARNINGS | Jul 30, 2026, 01:32 PM UTC
L
Why Teladoc Health Stock Is Dropping Thursday Following Soft Q3 Outlook
Teladoc Health Inc. (NYSE: TDOC ) shares are trading sharply lower during Thursday’s premarket session as investors digest second-quarter results and a cautious outlook that undercut the beat on earnings. Teladoc Health
EARNINGS | Jul 30, 2026, 01:00 PM UTC
H
Meta Posts Mixed Q2 Results, Joins Coursera, Qualcomm And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Thursday. Shares of Meta Platforms Inc (NASDAQ: META ) fell sharply in pre-market trading after the company posted mixed financial
EARNINGS | Jul 30, 2026, 12:03 PM UTC
H
TDOC Stay EW rated after results as BetterHelp remains a challenge @ BARC
TDOC Stay EW rated after results as BetterHelp remains a challenge @ BARC
EARNINGS | Jul 30, 2026, 11:17 AM UTC
H
Why Microsoft Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
Shares of Microsoft Corp (NASDAQ: MSFT ) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results. Microsoft reported fourth-quarter revenue of $90.01 billion, u
EARNINGS | Jul 30, 2026, 08:30 AM UTC
L
Why Teladoc Stock is Getting Crushed Wednesday After Hours
Shares of telehealth company Teladoc Health Inc (NYSE: TDOC ) are falling Wednesday after the company reported second-quarter financial results Wednesday after market close. Here are the key highlights. • Teladoc Health
EARNINGS | Jul 29, 2026, 09:00 PM UTC
H
TDOC -24.5%, CVNA -15.2%, TREE -12.1%, HLI -11.5%, WAY -8.1%, CWH -7.4%, ALGN -7.2%, WWD -6.7%, LXU -6.6%, META -6.4%, ALKT -5.3%, COUR -5.3
TDOC -24.5%, CVNA -15.2%, TREE -12.1%, HLI -11.5%, WAY -8.1%, CWH -7.4%, ALGN -7.2%, WWD -6.7%, LXU -6.6%, META -6.4%, ALKT -5.3%, COUR -5.3%, MX -3.6%, QCOM -3.6%, PFSI -3.3%, PDFS -3.1%, HOOD -2.9%, ORLY -2.8%, ICLR -2
EARNINGS | Jul 29, 2026, 08:44 PM UTC
L
TDOC reports Q2 loss, guides Q3 revenue below estimates
TDOC Q2 EPS loss and Q3 revenue guidance miss estimates
EARNINGS | Jul 29, 2026, 08:18 PM UTC
L
Teladoc Health Raises FY2026 GAAP EPS Guidance from $(1.05)-$(0.75) to $(1.00)-$(0.75) vs $(0.92) Est; Lowers FY2026 Sales Guidance from $2.
Teladoc Health (NYSE: TDOC ) raises FY2026 GAAP EPS guidance from $(1.05)-$(0.75) to $(1.00)-$(0.75) vs $(0.92) analyst estimate. Lowers FY2026 sales outlook from $2.481 billion-$2.576 billion to $2.362 billion-$2.447 bi
EARNINGS | Jul 29, 2026, 08:06 PM UTC
L
TDOC - Teladoc Health Reports Second Quarter 2026 Results
TDOC - Teladoc Health Reports Second Quarter 2026 Results
EARNINGS | Jul 29, 2026, 08:05 PM UTC
L
TDOC Teladoc Health RESULTS: Q2, Q2 REV $606.927M vs. EST $615.4M, Q2 basic EPS $-0.21, Q2 ADJ EBITDA $65.713M vs. EST $62M, Q2 Net Income $
TDOC Teladoc Health RESULTS: Q2, Q2 REV $606.927M vs. EST $615.4M, Q2 basic EPS $-0.21, Q2 ADJ EBITDA $65.713M vs. EST $62M, Q2 Net Income $-38.908M, Q2 EPS $-0.21, Teladoc Health Earnings Notes:, Outlook Q3 EPS $-0.3 to
EARNINGS | Jul 29, 2026, 08:05 PM UTC
L
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global le
EQUITY | Jul 03, 2026, 08:30 PM UTC